Teclison
Montclair
About Teclison
Teclison is to develop new drugs to treat cancer and other diseases with strong unmet medical needs.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: $1K – $10K
- Total funding: $5.9M
- Last round: Series Unknown (Feb 2022)
- Website: teclison.com
- Phone: [email protected]
Industries & Categories
Biotechnology
Social Profiles
Canonical: https://fsome.com/organization/teclison-21236 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.